The Calibr-Skaggs Institute for Innovative Medicines , the drug development division of Scripps Research, today announced a milestone in ...

Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...

ABOUT ORPHAN DRUG DESIGNATION The FDA grants Orphan Drug Designation to investigational drugs intended for the treatment of rare diseases affecting fewer than 200,000 people in the U.S. Benefits ...

GEO-CM04S1 Demonstrates Superior T Cell Responses Compared to mRNA Vaccine in Phase 2 Trial Among Immunocompromised Patients ...

SunRock Biopharma and Escugen have joined forces in a strategic partnership to co-develop SRB123, a First-in-Class ...

I n February 2025, it was revealed that a woman who as a child had undergone treatment for neuroblastoma was still ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

A diagnosis of 4 stage ovarian cancer can be devastating. However, advances in medical science are helping patients and ...